HIV / AIDS in the News

[AIDS 2026] [Press statement] Activists disrupt US Global AIDS Coordinator Jeff Graham at International AIDS Conference - European AIDS Treatment Group

 

Renee Heffron, Ph.D., M.P.H., on choice in HIV prevention | AIDS 2026 - Managed Healthcare Executive

 

[AIDS 2026] [Press release] Merck announces initial access plans for alimatravir, an investigational once-monthly oral HIV PrEP in Phase 3 development - European AIDS Treatment Group

 

New JIAS supplement on vaccines for the elimination of STIs - European AIDS Treatment Group

 

MSF calls for key HIV prevention drug to be made affordable - Yahoo

 

Gilead Targets Black Women With HIV Prevention Campaign 08/03/2026 - MediaPost

 

Opinion | Cuts to anti-AIDS foreign aid take a toll in Africa - The Washington Post

 

Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative - simplywall.st

 

IAS: Data revealing the impact of PEPFAR disruptions and advances in long-acting HIV prevention and treatment announced ahead of AIDS 2026 - European AIDS Treatment Group

 

Avantor (AVTR) Expands NuSil HIV Prevention Partnership With The Population Council - Yahoo Finance

 

Merck Announces Initial Access Plans For Alimatravir, Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis - Pulse 2.0

 

Saturday Longforms: PBGH wish list, drug prices, immigrants and cuts to family planning and HIV care. Animal photo, too - Substack

 

Lenacapavir may slow HIV infections 'but there's not enough' - dw.com

 

Preventing Those Living with HIV from Navigating the Journey Alone: Henrique’s Commitment - Gilead Sciences

 

WATCH: The amazing true story of the flight attendants who smuggled HIV medication to Brazil in the '80s - Queerty

 

The Hope of Organ Donations for People Living With HIV - POZ

 

Aging with HIV: The Latino Commission on AIDS honors National Latino Older Adults & HIV/AIDS Awareness Day - Los Angeles Blade

 

She Wasn't Supposed to Survive. Her Fight Saved Thousands - Haaretz

 

Merck & Co. details access strategy for once-monthly PrEP pill in late-stage testing - FirstWord Pharma

 

Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion? - simplywall.st

 

CDC funding shift puts $450K in Twin Cities HIV prevention at risk, group says - 5 EYEWITNESS NEWS

 

Unitaid strengthens African manufacturing capacity for next-generation HIV prevention medicines - Unitaid

 

World’s First Monthly Oral HIV Pill Moves Closer With Aspen Deal - Bloomberg.com

 

New Pennsylvania law will decriminalize HIV felony charge in prostitution cases - local21news.com

 

America’s 250th: Reflecting on Progress Against HIV - HIV.gov

 

Merck licenses experimental HIV pill to generic makers in 129 countries - Reuters

 

Merck stages expanded access to monthly HIV PrEP pill ahead of approval - Fierce Pharma

 

3 Facts About the Response to HIV/AIDS in Brunei - The Borgen Project

 

African Union Pushes for Greater Domestic Spending on Health Amid Reports of Huge Disruptions to HIV Services - Health Policy Watch

 

UNFPA at AIDS 2026: The 26th International AIDS Conference - United Nations Population Fund